Los Angeles Capital Management LLC / REGN
Los Angeles Capital Management LLC’s Regeneron Pharmaceuticals Position
Does Los Angeles Capital Management LLC own Regeneron Pharmaceuticals (REGN)? Yes — 78.9K shares worth $61M (+0.24% of its 13F portfolio) as of Q1 2026, down from 100.5K shares the prior filed quarter.
Position Value
$61M
Q1 2026
Shares
78.9K
% of Portfolio
+0.24%
Quarters Held
30
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 78.9K | $61M | +0.24% |
| Q4 2025 | 100.5K | $66M | +0.22% |
| Q3 2025 | 95.3K | $54M | +0.18% |
| Q2 2025 | 7.4K | $4M | +0.01% |
| Q1 2025 | 7.8K | $5M | +0.02% |
| Q4 2024 | 526 | $374,686 | 0.00% |
| Q3 2024 | 1.8K | $2M | +0.01% |
| Q2 2024 | 2.5K | $3M | +0.01% |
| Q1 2024 | 1.2K | $1M | 0.00% |
| Q4 2023 | 5.3K | $5M | +0.02% |
| Q3 2023 | 700 | $576,072 | 0.00% |
| Q2 2023 | 553 | $397,353 | 0.00% |
| Q1 2023 | 39.2K | $32M | +0.14% |
| Q4 2022 | 44.3K | $32M | +0.16% |
| Q3 2022 | 54.1K | $37M | +0.19% |
| Q2 2022 | 57.3K | $34M | +0.17% |
| Q1 2022 | 56.2K | $39M | +0.15% |
| Q4 2021 | 110.9K | $70M | +0.26% |
| Q3 2021 | 33.8K | $20M | +0.09% |
| Q2 2021 | 44.2K | $25M | +0.11% |
| Q1 2021 | 25.6K | $12M | +0.05% |
| Q4 2020 | 3.5K | $2M | +0.01% |
| Q3 2020 | 10.8K | $6M | +0.03% |
| Q2 2020 | 15.6K | $10M | +0.05% |
| Q1 2020 | 26.6K | $13M | +0.08% |
| Q4 2019 | 27.1K | $10M | +0.05% |
| Q3 2019 | 14.5K | $4M | +0.02% |
| Q2 2019 | 17.8K | $6M | +0.03% |
| Q1 2019 | 20.6K | $8M | +0.05% |
| Q4 2018 | 74.8K | $28M | +0.17% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Los Angeles Capital Management LLC’s full portfolio or all institutional holders of REGN.